论文信息 - Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts. - 字舞流文

Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts.

A. d’Arminio Monforte | C. Mussini | A. Cingolani | A. Tavelli | S. Lo Caputo | M. Puoti | A. Saracino | R. Rossotti | A. Soria | S. Bonora | C. Uberti-Foppa | L. Marinaro